A Study of Cetuximab Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2028-05-20

Target enrollment:

Participant gender:

A study of Cetuximab combined with Envolimab and mFOLFOX6 in Subjects with Advanced Colorectal Cancer

PHASE2

Tao Zhang